Issue 1/2018

MicroRNAs in triple-negative breast cancer (1 — 13)

Markéta Kolečková, Mária Janíková,  Zdeněk Kolář

DOI: 10.4149/neo_2018_170115N36

Bioinformatic analysis of changes in RNA polymerase II transcription stimulated by estradiol in MCF7 cells (14 — 20)

 Jie Wu, Yan Cai, Gaiping Zhao

DOI: 10.4149/neo_2018_161214N637

Triptolide induces mitochondrial apoptosis through modulating dual specificity phosphatase 1/mitogen-activated protein kinases cascade in osteosarcoma cells (21 — 33)

Wenxing Qin, Shuguang Li, Yuqing Miao, Qianwei Shi, Yan Wang, Jun Li, Zhe Chen,  Jiejun Wang,  Changquan Ling

DOI: 10.4149/neo_2018_170109N16

CCAAT enhancer binding protein β promotes tumor growth and inhibits apoptosis in prostate cancer by methylating estrogen receptor β (34 — 41)

Dong Li, Jiumin Liu, Shang Huang, Xuecheng Bi, Baojun Wang, Qingke Chen, Hanzhong Chen,  Xiaoyong Pu

DOI: 10.4149/neo_2018_161205N620

Beclin1 enhances cisplatin-induced apoptosis via Bcl-2 modulated autophagy in laryngeal carcinoma cells Hep-2 (42 — 47)

Mi Yang, Xin-Ming Yang, Dan-Hui Yin, Qing-Lai Tang, Lin Wang, Chao Huang, Ping Li,  Shi-Sheng Li

DOI: 10.4149/neo_2018_161102N528

MicroRNA-421 inhibits caspase-10 expression and promotes breast cancer progression (49 — 54)

Tang-Bin Hu,  Hong-Shen Chen, Ming-Qian Cao, Fang-Dong Guo, Xiao-Yu Cheng, Zhong-Bin Han, Mo-Qiang Li

DOI: 10.4149/neo_2018_170306N159

RNA interference-mediated silencing of aquaporin (AQP)-5 hinders angiogenesis of colorectal tumor by suppressing the production of vascular endothelial growth factor (55 — 65)

Wei Wang, Qing Li, Tao Yang, Dongsheng Li, Feng Ding, Hongzhi Sun,  Guang Bai

DOI: 10.4149/neo_2018_161019N487

Integrated network analysis to identify the key genes, transcription factors, and microRNAs involved in hepatocellular carcinoma (66 — 74)

Shu-Qing Shi, Jin-Jing Ke, Qi-Shun Xu, Wei-Quan Wu,  Yuan-Yu Wan

DOI: 10.4149/neo_2018_161215N642

Targeting RAD50 increases sensitivity to radiotherapy in colorectal cancer cells (75 — 80)

Cheng Chen, Yuan Wang, Jing-Feng Mei, Shou-Shan Li, Hong-Xia Xu, Hua-Ping Xiong,  Xiao-Hua Wang,  Xia He

DOI: 10.4149/neo_2018_170219N128

KrasG12D-LOH promotes malignant biological behavior and energy metabolism of pancreatic ductal adenocarcinoma cells through the mTOR signaling pathway (81 — 88)

Xia Shen, Li-Gong Chang, Ming-Yue Hu, Dan Yan, Ling-Na Zhou, Yu Ma, Sun-Kai Ling, Yu-Qi Fu, Shi-Yao Zhang, Bo Kong,  Pei-Lin Huang

DOI: 10.4149/neo_2018_170224N142

MiR-1-3p inhibits cell proliferation and invasion by regulating BDNF-TrkB signaling pathway in bladder cancer (89 — 96)

Lei Gao, Peng Yan, Feng-Fu Guo, Hong-Jun Liu,  Zhi-Feng Zhao

DOI: 10.4149/neo_2018_161128N594

Integrated analysis on the RNA-Seq data of liver hepatocellular carcinoma (97 — 103)

Hua Xue, Le Luo, Yu-Tong Yao, Ling-Ling Wei, Shao-Ping Deng,  Xiao-Lun Huang

DOI: 10.4149/neo_2018_170212N98

Proteomic alterations of fibroblasts induced by ovarian cancer cells reveal potential cancer targets (104 — 112)

 Xiao-Yan Zhang, Shan-Shan Hong, Meng Zhang, Qing-Qing Cai, Ming-Xing Zhang,  Cong-Jian Xu

DOI: 10.4149/neo_2018_101

Analysis of DNA methylation and microRNA expression in NUT (nuclear protein in testis) midline carcinoma of the sinonasal tract: a clinicopathological, immunohistochemical and molecular genetic study (113 — 123)

 Jan Laco, Helena Kovaříková, Marcela Chmelařová, Hana Vošmiková, Kateřina Sieglová, Ivana Bubancová, Pavel Dundr, Kristýna Němejcová, Jaroslav Michálek, Petr Čelakovský, Radovan Mottl, Igor Sirák, Milan Vošmik, Ivo Marek, Tomáš Geryk, Jan Mejzlík, J Šatanková, Aleš Ryška

DOI: 10.4149/neo_2018_161122N581

Pitfalls of Contrast Enhanced Ultrasound (CEUS) in determination of breast tumor biological dignity (124 — 131)

 Viera Lehotska, Katarina Rauova, Lucia Vanovcanova

DOI: 10.4149/neo_2018_170116N43

Effectiveness of nanoparticle albumin-bound paclitaxel plus carboplatin in non-small lung cancer patients with malignant pleural effusion (132 — 139)

 Nobuyuki Koyama, Yasutaka Watanabe, Yuki Iwai, Chihiro Miwa, Yoshiaki Nagai, Kazutetsu Aoshiba, Hiroyuki Nakamura

DOI: 10.4149/neo_2018_170206N78

PD-L1 expression can be regarded as prognostic factor for survival of non-small cell lung cancer patients after chemoradiotherapy (140 — 146)

Martina Vrankar, Matjaž Zwitter, Izidor Kern,  Karmen Stanič

DOI: 10.4149/neo_2018_170206N77

Predictors and prognostic implications of clinical decisions in patients with primary high-risk non-muscle-invasive bladder cancer – results of a cross country retrospective study (147 — 152)

 Sławomir Poletajew, Radosław Biernacki, Paweł Buraczyński, Jarosław Chojnacki, Stefan Czarniecki, Dominika Gajewska, Tomasz Pohaba, Joanna Sondka-Migdalska, Michał Skrzypczyk, Tomasz Suchojad, Dominik Wojtkowiak, Bogusław Zaforemski, Łukasz Zapała, Aleksandra Zemła, Piotr Radziszewski

DOI: 10.4149/neo_2018_170217N123

USF1 gene polymorphisms may associate with the efficacy and safety of chemotherapy based on paclitaxel and prognosis in the treatment of ovarian cancer (153 — 160)

 Hong Ye, Xiu-Juan Liu, Yan Hui, Yang-Huan Liang, Cai-Hong Li, Qiong Wan

DOI: 10.4149/neo_2018_170322N205

Distinct prognostic roles of HSPB1 expression in non-small cell lung cancer (161 — 166)

Zhi-Cheng Huang, Hang Li, Zhi-Qiang Sun, Jun Zheng, Rui-Kun Zhao, Jian Chen,  Shuang-Yan Sun,  Chun-Jiao Wu

DOI: 10.4149/neo_2018_102